Company Overview of Nohla Therapeutics Inc.
Nohla Therapeutics Inc. develops and manufactures ex vivo expanded universal donor cellular therapies to treat patients with cancer and other life threatening illnesses. Its universal donor product is used to treat hematopoietic recovery, chemotherapy induced neutropenia, and other medical indications. The company was founded in 2015 and is based in Seattle, Washington.
1616 Eastlake Avenue East
Seattle, WA 98102
Founded in 2015
Key Executives for Nohla Therapeutics Inc.
Nohla Therapeutics Inc. Key Developments
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
June 21, 2017
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
|NYC2012, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Nohla Therapeutics Inc., please visit nohlatherapeutics.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.